Viewing nowIrostastatin 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.

MFDS item code 201908080 · Approved 2019.11.26 · Insurance code 658603950
Treatment of hypercholesterolemia (primary, familial) and reduction of cardiovascular disease risk
This medication is primarily used as an adjunct when dietary therapy and exercise are not sufficient for patients with primary hypercholesterolemia and mixed dyslipidemia. It is also used as an adjunctive therapy in patients with homozygous familial hypercholesterolemia in conjunction with other lipid-lowering therapies. In patients with hypercholesterolemia, it lowers total cholesterol and LDL cholesterol levels, slowing the progression of atherosclerosis. It may also be used as an adjunct to diet for pediatric patients aged 10 to 17 years who meet specific criteria for heterozygous familial hypercholesterolemia. Additionally, it is effective as an adjunct to dietary therapy in patients with primary dysbetalipoproteinemia. Furthermore, it helps reduce the risk of stroke, myocardial infarction, and vascular revascularization procedures in men over 50 years and women over 60 years with elevated high-sensitivity C-reactive protein levels and additional cardiovascular disease risk factors.
Administer 5 mg once daily as the initial dose, at any time of the day regardless of meals. If a greater reduction in LDL cholesterol is required, adjust the maintenance dose to 10 mg once daily, modifying the dose at intervals of 4 weeks or more. The maximum daily dose can be increased up to 20 mg.
For pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia, the typical dose is 5 to 20 mg once daily. The dose should be adjusted individually according to the recommended therapeutic goals.
This medication should not be used in certain patients. For example, individuals who are allergic to the ingredients of this medication, those with active liver disease, muscle disorders, those taking cyclosporine, patients with severe renal impairment, and pregnant or nursing women should avoid using this medication. Additionally, individuals at high risk for muscle disorders should avoid high doses. This medication contains lactose, so those with lactose intolerance should also refrain from taking it. Caution is necessary for those with poor liver function or heavy alcohol consumption while taking this medication. It is advisable to monitor liver function by repeating liver enzyme tests before and during treatment. If symptoms of muscle pain or weakness occur, the physician should be notified immediately, and the medication may need to be discontinued if necessary. Particular caution is required for those with impaired kidney function, hypothyroidism, elderly patients, and those with alcohol abuse history who may be more susceptible to muscle disorders. During treatment with this medication, rare side effects such as skin rash, headache, dizziness, gastrointestinal discomfort, and muscle pain may occur. Most are mild and temporary, but if symptoms are severe or persist, medical consultation is required. Additionally, this medication may interact with other drugs, so it is essential to inform the physician or pharmacist if other medications are being taken. Particularly, concomitant use with specific antiviral medications, immunosuppressants, some antibiotics, and fibrate medications may increase the risk of muscle damage. Pregnant or nursing women should not use this medication, and women of childbearing potential should use appropriate contraceptive measures. Caution is necessary because taking this medication during pregnancy could harm the fetus. In the case of overdose, there is no specific antidote, so immediate medical attention should be sought for appropriate treatment, and liver function and muscle enzyme tests should be conducted to assess the condition. Dizziness may occur with this medication, so caution is advised during driving or operation of machinery.
Hypersensitivity reactions including urticaria and angioedema, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), jaundice, hepatitis, acute renal failure, oliguria, chest tightness, difficulty breathing, severe muscle weakness, ophthalmoplegia, rhabdomyolysis.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and humidity, so it should be stored in a tightly closed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the medication's effectiveness and safety.
Yellow, round, film-coated tablet
28 tablets/PTP (14 tablets/PTP × 2), 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.